Target intelligence / Profile preview

GABARAPL1 antisense RNA 1 (GABARAPL1-AS1)

Target: GABARAPL1-AS1
Molecular classification: Other (lncRNA), long non-coding RNA

Overview

GABARAPL1 antisense RNA 1 (GABARAPL1-AS1) is a long non-coding RNA transcribed from the opposite strand of the GABARAPL1 locus[2][4]. It is not a protein-coding gene and does not encode a receptor, enzyme, transporter, or other traditional therapeutic target. GABARAPL1-AS1 is categorized as an lncRNA based on current gene annotations. At this time, there is limited published information about its specific biological roles, disease relevance, or involvement in drug response.

Other names: GABARAPL1-AS1

Beyond the preview

Go deeper on GABARAPL1 antisense RNA 1 (GABARAPL1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GABARAPL1 antisense RNA 1 (GABARAPL1-AS1).

Explore the full profile